SLS was sold off hard the last two days despite positive news. The current price has acted as both support and resistance in recent months (shaded area).
With an RSI of 38 and the price well bellow the POC line (90 days) I think 9.08 may have been the bottom. I think the drop had more to do with large investors rebalancing for the 2nd half of the year than...
Today's candle took out two fibonacci levels to close above the .38 fib level. The set up resembles a jacked up cup and handle. After a healthy retracement from its recent high I am looking for a move up the fibonacci scale.
target: 11.85, 12.19, 12,70, 13.35
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States.
Sellas Life Sciences Group Inc (NASDAQ:SLS) After a solid breakout on rising volume SLS has pulled back to support near $9 and should set up for its next upside move. Things are now beginning to turn in favor of the Bulls. The MACD confirms the recent jump and daily RSI also shows that there's more upside to come. SLS should be watched closely, it could pay off...
This is an incredible long opportunity, the stock shows huge institutional interest, while also being hugely oversold, combined with the recent breakout. this is exactly what I have been waiting for, this has an outstanding risk to reward ratio.
Why SELLAS Life Sciences Is Surging Premarket?
SELLAS Life Sciences is captivating investors thanks to its late-stage cancer vaccine
Thanks to some news in December in the biopharma space, SLS stock is racing higher. So what was that news? And what else do you need to know?
its leading candidate Galinpepimut-S is making its way through Phase 3.
This...
Looks like we will get some more movement in the next few days. Hope we can hold the support at 5.50 and follow the trendline that was started a month ago before the spike
Great resistance at 7$, with low volume. It looks like it won't go under 7$ again for a while. SLS entered into a share purchase agreement with institutional investors! 7$ per share.Total 16.2 Million $. Once the registered direct offering is closed (yesterday or today? im not sure), I think we will see it at the 10$ level. Institutional investors get in at 7, of...
SLS has been moving between 12 and 11 today. It might be collecting some power for an another spike later today or on Monday. Check the volume and wait for the news later today. My target is near 20$. We will see. Good luck. This is my first post.
Alert set for cross above $3.00
SELLAS Life Sciences Group, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the development and commercialization of novel cancer immunotherapeutics for cancer indications. Its product galinpepimut-S, or GPS, is an immunotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK,...
There has not been much good news on this stock lately, but looks like it is trying to make a recovery today. We will be watching this stock for a possible continuation trade tomorrow.
